Sulkes A - Search Results

1

Differences in Toxicity Between Ashkenazi and Sephardic Jews With Colon Cancer Treated With Adjuvant Chemotherapy: A Prospective Study.

Brenner B, Stern Y, Gordon N, Fuks T, Granot T, Dreyer J, Sulkes A. Brenner B, et al. Among authors: sulkes a. Anticancer Res. 2023 Jan;43(1):239-245. doi: 10.21873/anticanres.16155. Anticancer Res. 2023. PMID: 36585205

2

Strong Synergic Growth Inhibition and Death Induction of Cancer Cells by Astragalus membranaceus and Vaccaria hispanica Extract.

Cohen Z, Maimon Y, Samuels N, Brand H, Sulkes A, Brenner B, Berger R. Cohen Z, et al. Among authors: sulkes a. Cancers (Basel). 2022 Nov 26;14(23):5833. doi: 10.3390/cancers14235833. Cancers (Basel). 2022. PMID: 36497315 Free PMC article.

3

Early prediction of residual disease after neoadjuvant chemoradiotherapy and cetuximab for locally advanced esophageal cancer using ¹⁸F-FDG PET-CT imaging: a prospective cohort study.

Brenner B, Kundel Y, Cohen Z, Brand H, Gordon N, Sulkes A, Morgenstern S, Menasherov N, Kashtan H, Groshar D, Domachevsky L, Bernstine H. Brenner B, et al. Among authors: sulkes a. J Gastrointest Oncol. 2022 Dec;13(6):2721-2735. doi: 10.21037/jgo-22-352. J Gastrointest Oncol. 2022. PMID: 36636052 Free PMC article.

4

Docetaxel-induced Acute Myositis.

Sulkes A, Reinhorn D, Cohen T, Peysakhovich T, Neiman V, Brenner B. Sulkes A, et al. Isr Med Assoc J. 2023 Jan;25(1):75-76. Isr Med Assoc J. 2023. PMID: 36718745 Free article. No abstract available.

5

Mitomycin C and capecitabine: An additional option as an advanced line therapy in patients with metastatic colorectal cancer.

Mullin G, Sternschuss M, Landman Y, Sulkes A, Brenner B. Mullin G, et al. Among authors: sulkes a. World J Gastrointest Oncol. 2023 Nov 15;15(11):1913-1924. doi: 10.4251/wjgo.v15.i11.1913. World J Gastrointest Oncol. 2023. PMID: 38077638 Free PMC article.

6

Comment to Moady et al. A Comparative Retrospective Study of Patients with Takotsubo Syndrome and Acute Coronary Syndrome.

Sulkes A, Itzhaki Ben Zadok O, Neiman V, Brenner B. Sulkes A, et al. Isr Med Assoc J. 2021 Jun;23(6):395-396. Isr Med Assoc J. 2021. PMID: 34155860 Free article. No abstract available.

7

Taxane versus vinorelbine in combination with trastuzumab and pertuzumab for first-line treatment of metastatic HER2-positive breast cancer: a retrospective two-center study.

Reinhorn D, Kuchuk I, Shochat T, Nisenbaum B, Sulkes A, Hendler D, Rotem O, Tsoref D, Olitzky O, Goldvaser H, Sarfaty M, Neiman V, Prus J, Gottfried M, Yust-Katz S, Yerushalmi R. Reinhorn D, et al. Among authors: sulkes a. Breast Cancer Res Treat. 2021 Jul;188(2):379-387. doi: 10.1007/s10549-021-06198-4. Epub 2021 Mar 27. Breast Cancer Res Treat. 2021. PMID: 33772709

8

[Merkel Cell Carcinoma].

Sulkes A, Fenig E. Sulkes A, et al. Harefuah. 2021 Mar;160(3):189. Harefuah. 2021. PMID: 33749185 Hebrew. No abstract available.

9

ERBB2 Pathway in Biliary Tract Carcinoma: Clinical Implications of a Targetable Pathway.

Jacobi O, Ross JS, Goshen-Lago T, Haddad R, Moore A, Sulkes A, Brenner B, Ben-Aharon I. Jacobi O, et al. Among authors: sulkes a. Oncol Res Treat. 2021;44(1-2):20-27. doi: 10.1159/000511919. Epub 2020 Dec 4. Oncol Res Treat. 2021. PMID: 33279901

10

Prospective Long-Term Follow-Up of Pulmonary Diffusion Capacity Reduction Caused by Dose-Dense Chemotherapy in Patients with Breast Cancer.

Landman Y, Stemmer SM, Sulkes A, Neiman V, Granot T, Hendler D, Kramer MR, Gelmon K, Yerushalmi R. Landman Y, et al. Among authors: sulkes a. J Oncol. 2019 Oct 28;2019:2584859. doi: 10.1155/2019/2584859. eCollection 2019. J Oncol. 2019. PMID: 31772578 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters